Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2 ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® ...

24,000 nurses with California Nurses Association reach deal with UC

Negotiators with the University of California and the California Nurses Association said they reached a tentative 4-year ...
Shanghai Metals Market

Retrospective and Outlook on EU Import Quota Policy — The Final Spree for Exports to Europe and the Systemic Reshaping of Global Trade Rules

The EU is driving a policy-driven industrial revolution. Its Quota + CBAM combination establishes a new set of market access rules. This means that future steel products entering the EU market must ...